[Federal Register Volume 63, Number 149 (Tuesday, August 4, 1998)]
[Notices]
[Pages 41572-41573]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20719]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[INFO-98-24]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c) (2) (A) of 
the Paperwork Reduction Act of 1995 for opportunity for public comment 
on proposed data collection projects, the Centers for Disease Control 
and Prevention (CDC) will publish periodic summaries of proposed 
projects. To request more information on the proposed projects or to 
obtain a copy of the data collection plans and instruments, call the 
CDC Reports Clearance Officer at (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the

[[Page 41573]]

agency's estimate of the burden of the proposed collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; and (d) ways to minimize the burden of 
the collection of information on respondents, including through the use 
of automated collection techniques or other forms of information 
technology. Send comments to Seleda Perryman, CDC Assistant Reports 
Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. 
Written comments should be received within 60 days of this notice. 
Comments regarding this information collection are best assured of 
having their full effect if received within 60 days of the date of this 
publication.

Proposed Projects

    1. Requirement for a Special Permit to Import Cynomolgus-African 
Green or Rhesus Monkeys--(0920-0263)--Extension--National Center for 
Infectious Disease (NCID) Division of Quarantine--A registered importer 
nonhuman primates must submit to the Director, CDC, a written plan 
which specifies the steps that will be taken to prevent exposure of 
persons and animals during the entire importation and quarantine 
process for the arriving nonhuman primates. Under the special permit 
arrangement, registered importers must submit a plan to CDC for the 
importation and quarantine if they wish to import the specific monkeys 
covered. The plan must address disease prevention procedures to be 
carried out in every step of the chain of custody of such monkeys, from 
embarkation in the country of origin to release from quarantine. 
Information such as species, origin and intended use for monkeys, 
transit information, isolation and quarantine procedures, and 
procedures for testing of quarantined animals is necessary for CDC to 
make public health decisions. This information enables CDC to evaluate 
compliance with the standards and determine whether the measures being 
taken to prevent exposure of persons and animals during importation are 
adequate. Once CDC is assured, through the monitoring of shipments 
(normally no more than 2), that the provisions of a special permit plan 
are being followed by a new permit holder, and that the use of adequate 
disease control practices is being demonstrated, the special permit is 
extended to cover the receipt of additional shipments under the same 
plan for a period of 180 days, and may be renewed upon request. This 
eliminates the burden on importers to repeatedly report identical 
information, requiring only that specific shipment itineraries and 
information on changes to the plan which require approval be submitted.
    The respondents are commercial or not-for-profit importers of 
nonhuman primates. We are requesting clearance for 3 years. Total cost 
to Respondents: $350 (14 x $25)

----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Avg. burden/                 
                   Respondents                       Number of      responses/    responses  (in   Total burden 
                                                    respondents     respondents        hrs.)         (in hrs.)  
----------------------------------------------------------------------------------------------------------------
Businesses......................................               5               5    <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4e7c0e7e607b">[email protected]</a>; <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="cffc8fffe1fe">[email protected]</a>             6.5
Organizations...................................              15               5             0.1             7.5
                                                 ---------------------------------------------------------------
      Total.....................................  ..............  ..............  ..............              14
----------------------------------------------------------------------------------------------------------------

    Dated: July 29, 1998.
Charles W. Gollmar,
Acting Associate Director for Policy, Planning and Evaluation Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 98-20719 Filed 8-3-98; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>